Michel Cailleret
Corbeil-essonnes, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Generation of two iPSC lines each carrying a stop codon mutation, c.366T > A (p.Y122X) and c.1657C > T (p.R553X), in the CFTR gene from the parental line PCIi033-A using CRISPR/Cas9.
Journal: Stem cell research
Published: March 18, 2026
Generation of two iPSC lines carrying two cystic fibrosis rare intronic mutations c.1585-1G>A and c.1680-886A>G in the CFTR gene of the parental line PCIi033-A using CRISPR/Cas tools.
Journal: Stem cell research
Published: March 18, 2026
Integrative analysis of drug-gene signatures in human pluripotent stem cells reveals prazosin as a novel SQSTM1 regulator for ALS therapeutics.
Journal: Stem cell reports
Published: November 25, 2025
CRISPR-Cas9 genome editing in the parental iPSC line PCIi033-A to introduce the homozygous mutation p.F508del (c.1521_1523del) in the CFTR gene.
Journal: Stem cell research
Published: October 07, 2025
Alternative Splicing of SORBS1 Affects Neuromuscular Junction Integrity in Myotonic Dystrophy Type 1.
Journal: Journal of cachexia, sarcopenia and muscle
Published: March 01, 2025
Mono- and Biallelic Inactivation of Huntingtin Gene in Patient-Specific Induced Pluripotent Stem Cells Reveal HTT Roles in Striatal Development and Neuronal Functions.
Journal: Journal of Huntington's disease
Published: March 01, 2024
Semi-automated optimized method to isolate CRISPR/Cas9 edited human pluripotent stem cell clones.
Journal: Stem cell research & therapy
Published: December 14, 2022
Human iPSC-derived neurons reveal early developmental alteration of neurite outgrowth in the late-occurring neurodegenerative Wolfram syndrome.
Journal: American journal of human genetics
Published: May 20, 2021
Rescuing compounds for Lesch-Nyhan disease identified using stem cell-based phenotypic screening.
Journal: JCI insight
Published: July 25, 2019
Cucurbitacin I elicits the formation of actin/phospho-myosin II co-aggregates by stimulation of the RhoA/ROCK pathway and inhibition of LIM-kinase.
Journal: Biochemical pharmacology
Published: October 08, 2015
Last Updated: 09/26/2026